These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10664829

  • 1. Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.
    Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, Marzocchi GF, Delsignore R, Brambilla F.
    Biol Psychiatry; 2000 Jan 15; 47(2):127-36. PubMed ID: 10664829
    [Abstract] [Full Text] [Related]

  • 2. Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans.
    Gerra G, Zaimovic A, Moi G, Giusti F, Gardini S, Delsignore R, Laviola G, Macchia T, Brambilla F.
    Behav Brain Res; 2002 Aug 21; 134(1-2):403-10. PubMed ID: 12191827
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity.
    Gerra G, Bassignana S, Zaimovic A, Moi G, Bussandri M, Caccavari R, Brambilla F, Molina E.
    Psychiatry Res; 2003 Sep 30; 120(2):115-24. PubMed ID: 14527643
    [Abstract] [Full Text] [Related]

  • 5. Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA.
    Poland RE, Lutchmansingh P, McCracken JT, Zhao JP, Brammer GL, Grob CS, Boone KB, Pechnick RN.
    Psychopharmacology (Berl); 1997 Jun 30; 131(4):411-9. PubMed ID: 9226745
    [Abstract] [Full Text] [Related]

  • 6. Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: psychobiological correlates.
    Gerra G, Zaimovic A, Ampollini R, Giusti F, Delsignore R, Raggi MA, Laviola G, Macchia T, Brambilla F.
    J Subst Abuse; 2001 Jun 30; 13(4):471-91. PubMed ID: 11775077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.
    McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA.
    Psychopharmacology (Berl); 1999 Nov 30; 147(1):56-65. PubMed ID: 10591869
    [Abstract] [Full Text] [Related]

  • 10. Neuroendocrine correlates of temperamental traits in humans.
    Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F.
    Psychoneuroendocrinology; 2000 Jul 30; 25(5):479-96. PubMed ID: 10818282
    [Abstract] [Full Text] [Related]

  • 11. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC, Sands HR, Jones L, Clow A, Evans P, Downey LA, Stalder T.
    Eur Neuropsychopharmacol; 2014 Mar 30; 24(3):369-74. PubMed ID: 24333019
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.
    Hatzidimitriou G, Tsai EH, McCann UD, Ricaurte GA.
    Synapse; 2002 Apr 30; 44(1):51-7. PubMed ID: 11842446
    [Abstract] [Full Text] [Related]

  • 15. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar 30; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 16. Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.
    Tancer M, Johanson CE.
    Drug Alcohol Depend; 2003 Oct 24; 72(1):33-44. PubMed ID: 14563541
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.